ferumoxtran-10
information and resources from the National Cancer Institute
NCI Thesaurus | ferumoxtran-10
A synthetic ultrasmall superparamagnetic iron oxide composed of dextran-coated iron oxide nanoparticles (also known as 'ultrasmall particulate iron oxides' or USPIO). Ferumoxtran-10, which accumulates in non-cancerous lymphatic tissue, is used as a molecular resonance imaging (MRI) contrast agent. NCI Thesaurus | ferumoxtran-10
A synthetic ultrasmall superparamagnetic iron oxide composed of dextran-coated iron oxide nanoparticles (also known as 'ultrasmall particulate iron oxides' or USPIO). Ferumoxtran-10, which accumulates in non-cancerous lymphatic tissue, is used as a molecular resonance imaging (MRI) contrast agent.
|
|
|
|
news articles
Cytogen Announces Schedule for Clinical Data Presentations at ... Mar 23, 2006
PharmaLive.com (press release), Cytogen also has exclusive United States marketing rights to COMBIDEX(R) (ferumoxtran-10) for all applications, and the exclusive right to market and sell ...
Cytogen to Raise $13.3 Million Through Sale of Common Stock and ... Dec 13, 2005
PR Newswire (press release), Cytogen also has exclusive United States marketing rights to COMBIDEX(R) (ferumoxtran-10) for all applications, and the exclusive right to market and sell ...
|
|
